Remdesivir’s Path To Orphan Designation Could Be Exploited By Others, Experts Warn

 
• By Derrick Gingery
  
Orphan Drug_1200
If the loophole is not closed, more sponsors could follow the pathway that allowed remdesivir to receive an orphan drug designation as a coronavirus treatment, the writers of a JAMA Internal Medicine article argued. • Source: Shutterstock

More from Rare Diseases

More from Pink Sheet